HPR66 Cost Savings Associated with One-Stage vs Two-Stage Spinal Cord Stimulation from Medicare Perspective

Abstract

Spinal cord stimulation (SCS) is an FDA approved therapy for failed back surgery syndrome. In clinical practice typically patients undergo a trial phase, in which temporary electrodes are implanted in the patients. Only those patients who experience adequate pain relief progress to the next step where the SCS electrodes and the pulse generator device are permanently implanted (trial success rate). Centers for Medicare & Medicaid Services (CMS) policy mandates this two-stage process for reimbursement eligibility.